Sheilagh M. Maguiness, MD; Terry T. Farsani, MD; Daniel C. Zedek, MD; Timothy G. Berger, MD
Dr. Maguiness is from the University of Minnesota, Minneapolis. Dr. Farsani is from the Palo Alto Medical Foundation, Mountain View, California. Drs. Zedek and Berger are from the University of California, San Francisco.
The authors report no conflict of interest.
Correspondence: Terry T. Farsani, MD, Palo Alto Medical Foundation, 701 E El Camino Real, Mountain View, CA 94306 (tfarsani@gmail.com).
The use of imiquimod in patients with a personal or family history of lupus erythematosus or those with a personal history of an autoimmune blistering disorder should be undertaken with caution until more is known.
